PAFAH1B2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.084000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.688200E-01
Normal-vs-Stage2
7.649400E-01
Normal-vs-Stage3
1.032760E-01
Normal-vs-Stage4
2.632800E-01
Stage1-vs-Stage2
9.213600E-01
Stage1-vs-Stage3
3.892000E-02
Stage1-vs-Stage4
1.879180E-01
Stage2-vs-Stage3
7.304400E-02
Stage2-vs-Stage4
1.398790E-01
Stage3-vs-Stage4
3.304000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.290400E-01
Normal-vs-AfricanAmerican
4.314600E-01
Normal-vs-Asian
7.839000E-01
Caucasian-vs-AfricanAmerican
2.575800E-01
Caucasian-vs-Asian
2.985600E-01
AfricanAmerican-vs-Asian
1.971980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.467800E-01
Normal-vs-Female
7.673000E-01
Male-vs-Female
6.690400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.663400E-01
Normal-vs-Age(41-60Yrs)
4.806000E-01
Normal-vs-Age(61-80Yrs)
9.542600E-01
Normal-vs-Age(81-100Yrs)
7.301800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.396000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.406800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.417400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.567920E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.679500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.372000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.748400E-01
Normal-vs-Daily Drinker
7.610000E-01
Normal-vs-Weekly Drinker
9.711800E-01
Normal-vs-Occasional Drinker
5.254800E-01
Normal-vs-Social Drinker
5.683400E-01
Non Drinker-vs-Daily Drinker
4.802200E-01
Non Drinker-vs-Weekly Drinker
9.016600E-01
Non Drinker-vs-Occasional Drinker
1.802050E-01
Non Drinker-vs-Social Drinker
2.777800E-01
Daily Drinker-vs-Weekly Drinker
6.270600E-01
Daily Drinker-vs-Occasional Drinker
6.967800E-02
Daily Drinker-vs-Social Drinker
1.106630E-01
Weekly Drinker-vs-Occasional Drinker
2.213200E-01
Weekly Drinker-vs-Social Drinker
2.930800E-01
Occasional Drinker-vs-Social Drinker
8.423800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.572210E-01
Normal-vs-Grade 2
3.327800E-02
Normal-vs-Grade 3
2.008100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.324100E-02
Grade 1-vs-Grade 3
6.735800E-03
Grade 1-vs-Grade 4
1.572210E-01
Grade 2-vs-Grade 3
5.782400E-02
Grade 2-vs-Grade 4
3.327800E-02
Grade 3-vs-Grade 4
2.008100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.847000E-01
Normal-vs-NonDiabetic
8.885400E-01
Diabetic-vs-NonDiabetic
7.139400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.129800E-01
Normal-vs-NoPancreatitis
8.664200E-01
Pancreatitis-vs-NoPancreatitis
8.777800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.981000E-01
Normal-vs-N1
7.392200E-01
N0-vs-N1
5.092400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.496200E-01
Normal-vs-TP53-NonMutant
8.853200E-01
TP53-Mutant-vs-TP53-NonMutant
2.668300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
